IMPACT Trial: Intervention to iMProve AdherenCe equitably
Contact:
NCT Number:
Protocol:
AAAT8817
Study Status:
Active/Enrolling
Population:
Adult
Phase:
NA
Many patients with breast cancer, who also take medicine to prevent heart disease such as a blood pressure medicine or a cholesterol medicine, experience frustration with the large number and difficult scheduling of their medications, known as “pill burden”. This study will help us find out how much “pill burden” exists in subjects with cancer at various stages, and how this intervention can help. Results of this study may help us figure out the best way to help patients manage their medications in the future.
Are you Eligible? (Inclusion Criteria)
- Are you diagnosed with stage I- III breast cancer?
- Do you speak English?
- Are you taking medication for your cardiovascular disease?
Specialty Area(s)
Principal Investigator
Trial Location(s)
CUIMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032